Louisiana has ceased Medicaid reimbursement for gender-affirming care prescriptions linked to certain diagnosis codes, affecting many transgender individuals. This policy change was implemented without legislative process, perceived as part of an anti-trans agenda. Consequently, many are facing financial burdens for necessary medications. Gender-affirming care encompasses treatments aligning individuals' bodies with their identified gender. Despite a ban on such care for transgender youth, it remains legal for adults. The Williams Institute reports that a significant number of LGBTQ+ adults in Louisiana rely on Medicaid for healthcare.
Transgender Louisianians will no longer receive Medicaid reimbursement for gender-affirming care prescriptions if their provider uses certain gender-related diagnosis codes, according to multiple LGBTQ+ organizations.
The state instilled its anti-trans agenda through obscure, extralegal bureaucratic maneuvers, resulting in thousands losing coverage for trans medicine and incurring unexpected out-of-pocket costs.
Gender-affirming care is a catch-all term for medical treatments given to align physical bodies with identified gender, administered to both transgender and cisgender people.
Louisiana's Medicaid program estimates indicate that LGBTQ+ adults are twice as likely to participate compared to non-LGBTQ+ adults.
Collection
[
|
...
]